Table of Content



Chapter 1. Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data sources

1.4.1. Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. Cancer gene therapy industry 360 degree synopsis, 2014 - 2025

2.1.1. Business trends

2.1.2. Type trends

2.1.3. Product trends

2.1.4. End-use trends

2.1.5. Regional trends

Chapter 3. Cancer Gene Therapy Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2014 - 2018 (USD Million)

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Increasing prevalence of cancer across the globe

3.3.1.2. Technological advancements in cancer gene therapy in developed regions

3.3.1.3. Rising awareness regarding availability of cancer gene therapy in developing and underdeveloped countries

3.3.1.4. Increasing geriatric population in Europe

3.3.2. Industry pitfalls & challenges

3.3.2.1. High cost of cancer gene therapy

3.4. Growth potential analysis

3.4.1. By type

3.4.2. By product

3.4.3. By end-use

3.5. Pipeline analysis

3.6. Regulatory landscape

3.7. Commercial deals in gene therapy

3.8. Porter’s analysis

3.9. Competitive landscape, 2018

3.9.1. Strategy dashboard

3.10. PESTEL analysis

Chapter 4. Cancer Gene Therapy Market, By Type

4.1. Key segment trends

4.2. Ex-vivo

4.2.1. Market size, by region, 2014 - 2025 (USD Million)

4.3. In-vivo

4.3.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 5. Cancer Gene Therapy Market, By Product

5.1. Key segment trends

5.2. Viral vectors

5.2.1. Market size, by region, 2014 - 2025 (USD Million)

5.2.2. Adenoviruses

5.2.2.1. Market size, by region, 2014 - 2025 (USD Million)

5.2.3. Lentiviruses

5.2.3.1. Market size, by region, 2014 - 2025 (USD Million)

5.2.4. Retrovirus

5.2.4.1. Market size, by region, 2014 - 2025 (USD Million)

5.2.5. Adeno associated virus

5.2.5.1. Market size, by region, 2014 - 2025 (USD Million)

5.2.6. Herpes simplex virus

5.2.6.1. Market size, by region, 2014 - 2025 (USD Million)

5.2.7. Vaccinia virus

5.2.7.1. Market size, by region, 2014 - 2025 (USD Million)

5.2.8. Others

5.2.8.1. Market size, by region, 2014 - 2025 (USD Million)

5.3. Non-viral vectors

5.3.1. Market size, by region, 2014 - 2025 (USD Million)

5.4. Others

5.4.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 6. Cancer Gene Therapy Market, By End-use

6.1. Key segment trends

6.2. Biopharma companies

6.2.1. Market size, by region, 2014 - 2025 (USD Million)

6.3. Research institutes

6.3.1. Market size, by region, 2014 - 2025 (USD Million)

6.4. Others

6.4.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 7. Cancer Gene Therapy Market, By Region

7.1. Key regional trends

7.2. North America

7.2.1. Market size, by country, 2014 - 2025 (USD Million)

7.2.2. Market size, by type, 2014 - 2025 (USD Million)

7.2.3. Market size, by product, 2014 - 2025 (USD Million)

7.2.4. Market size, by end-use, 2014 - 2025 (USD Million)

7.2.5. U.S.

7.2.5.1. Market size, by type, 2014 - 2025 (USD Million)

7.2.5.2. Market size, by product, 2014 - 2025 (USD Million)

7.2.5.3. Market size, by end-use, 2014 - 2025 (USD Million)

7.2.6. Canada

7.2.6.1. Market size, by type, 2014 - 2025 (USD Million)

7.2.6.2. Market size, by product, 2014 - 2025 (USD Million)

7.2.6.3. Market size, by end-use, 2014 - 2025 (USD Million)

7.3. Europe

7.3.1. Market size, by country, 2014 - 2025 (USD Million)

7.3.2. Market size, by type, 2014 - 2025 (USD Million)

7.3.3. Market size, by product, 2014 - 2025 (USD Million)

7.3.4. Market size, by end-use, 2014 - 2025 (USD Million)

7.3.5. Germany

7.3.5.1. Market size, by type, 2014 - 2025 (USD Million)

7.3.5.2. Market size, by product, 2014 - 2025 (USD Million)

7.3.5.3. Market size, by end-use, 2014 - 2025 (USD Million)

7.3.6. UK

7.3.6.1. Market size, by type, 2014 - 2025 (USD Million)

7.3.6.2. Market size, by product, 2014 - 2025 (USD Million)

7.3.6.3. Market size, by end-use, 2014 - 2025 (USD Million)

7.3.7. France

7.3.7.1. Market size, by type, 2014 - 2025 (USD Million)

7.3.7.2. Market size, by product, 2014 - 2025 (USD Million)

7.3.7.3. Market size, by end-use, 2014 - 2025 (USD Million)

7.3.8. Italy

7.3.8.1. Market size, by type, 2014 - 2025 (USD Million)

7.3.8.2. Market size, by product, 2014 - 2025 (USD Million)

7.3.8.3. Market size, by end-use, 2014 - 2025 (USD Million)

7.3.9. Spain

7.3.9.1. Market size, by type, 2014 - 2025 (USD Million)

7.3.9.2. Market size, by product, 2014 - 2025 (USD Million)

7.3.9.3. Market size, by end-use, 2014 - 2025 (USD Million)

7.4. Asia Pacific

7.4.1. Market size, by country, 2014 - 2025 (USD Million)

7.4.2. Market size, by type, 2014 - 2025 (USD Million)

7.4.3. Market size, by product, 2014 - 2025 (USD Million)

7.4.4. Market size, by end-use, 2014 - 2025 (USD Million)

7.4.5. China

7.4.5.1. Market size, by type, 2014 - 2025 (USD Million)

7.4.5.2. Market size, by product, 2014 - 2025 (USD Million)

7.4.5.3. Market size, by end-use, 2014 - 2025 (USD Million)

7.4.6. Japan

7.4.6.1. Market size, by type, 2014 - 2025 (USD Million)

7.4.6.2. Market size, by product, 2014 - 2025 (USD Million)

7.4.6.3. Market size, by end-use, 2014 - 2025 (USD Million)

Chapter 8. Company Profiles

8.1. Sirion Biotech

8.1.1. Business overview

8.1.2. Financial data

8.1.3. Product landscape

8.1.4. Strategic outlook

8.1.5. SWOT analysis

8.2. Vigene Biosciences

8.2.1. Business overview

8.2.2. Financial data

8.2.3. Product landscape

8.2.4. Strategic outlook

8.2.5. SWOT analysis

8.3. Bluebird bio

8.3.1. Business overview

8.3.2. Financial data

8.3.3. Product landscape

8.3.4. Strategic outlook

8.3.5. SWOT analysis

8.4. Ziopharm

8.4.1. Business overview

8.4.2. Financial data

8.4.3. Product landscape

8.4.4. Strategic outlook

8.4.5. SWOT analysis

8.5. Cellectis

8.5.1. Business overview

8.5.2. Financial data

8.5.3. Product landscape

8.5.4. Strategic outlook

8.5.5. SWOT analysis

8.6. Cobra

8.6.1. Business overview

8.6.2. Financial data

8.6.3. Product landscape

8.6.4. Strategic outlook

8.6.5. SWOT analysis

8.7. Finvector

8.7.1. Business overview

8.7.2. Financial data

8.7.3. Product landscape

8.7.4. Strategic outlook

8.7.5. SWOT analysis

8.8. Uniqure

8.8.1. Business overview

8.8.2. Financial data

8.8.3. Product landscape

8.8.4. Strategic outlook

8.8.5. SWOT analysis

8.9. Sarepta Therapeutics

8.9.1. Business overview

8.9.2. Financial data

8.9.3. Product landscape

8.9.4. Strategic outlook

8.9.5. SWOT analysis

8.10. Caribou

8.10.1. Business overview

8.10.2. Financial data

8.10.3. Product landscape

8.10.4. Strategic outlook

8.10.5. SWOT analysis



List of Tables

Data Tables

TABLE 1. Cancer gene therapy industry 360 degree synopsis, 2014 - 2025

TABLE 2. Cancer gene therapy market, 2014 - 2018 (USD Million)

TABLE 3. Cancer gene therapy market, 2019 - 2025 (USD Million)

TABLE 4. Cancer gene therapy market, by type, 2014 - 2018 (USD Million)

TABLE 5. Cancer gene therapy market, by type, 2019 - 2025 (USD Million)

TABLE 6. Cancer gene therapy market, by product, 2014 - 2018 (USD Million)

TABLE 7. Cancer gene therapy market, by product, 2019 - 2025 (USD Million)

TABLE 8. Cancer gene therapy market, by end-use, 2014 - 2018 (USD Million)

TABLE 9. Cancer gene therapy market, by end-use, 2019 - 2025 (USD Million)

TABLE 10. Cancer gene therapy market, by region, 2014 - 2018 (USD Million)

TABLE 11. Cancer gene therapy market, by region, 2019 - 2025 (USD Million)

TABLE 12. Industry impact forces

TABLE 13. In-vivo market size, by region, 2014 - 2018 (USD Million)

TABLE 14. In-vivo market size, by region, 2019 - 2025 (USD Million)

TABLE 15. Ex-vivo market size, by region, 2014 - 2018 (USD Million)

TABLE 16. Ex-vivo market size, by region, 2019 - 2025 (USD Million)

TABLE 17. Viral market size, by region, 2014 - 2018 (USD Million)

TABLE 18. Viral market size, by region, 2019 - 2025 (USD Million)

TABLE 19. Adenoviruses market size, by region, 2014 - 2018 (USD Million)

TABLE 20. Adenoviruses market size, by region, 2019 - 2025 (USD Million)

TABLE 21. Lentiviruses market size, by region, 2014 - 2018 (USD Million)

TABLE 22. Lentiviruses market size, by region, 2019 - 2025 (USD Million)

TABLE 23. Retrovirus market size, by region, 2014 - 2018 (USD Million)

TABLE 24. Retrovirus devices market size, by region, 2019 - 2025 (USD Million)

TABLE 25. Adeno Associated Virus market size, by region, 2014 - 2018 (USD Million)

TABLE 26. Adeno Associated Virus market size, by region, 2019 - 2025 (USD Million)

TABLE 27. Herpes Simplex Virus market size, by region, 2014 - 2018 (USD Million)

TABLE 28. Herpes Simplex Virus market size, by region, 2019 - 2025 (USD Million)

TABLE 29. Vaccinia Virus market size, by region, 2014 - 2018 (USD Million)

TABLE 30. Vaccinia Virus devices market size, by region, 2019 - 2025 (USD Million)

TABLE 31. Others market size, by region, 2014 - 2018 (USD Million)

TABLE 32. Others market size, by region, 2019 - 2025 (USD Million)

TABLE 33. Non-viral vectors market size, by region, 2014 - 2018 (USD Million)

TABLE 34. Non-viral vectors market size, by region, 2019 - 2025 (USD Million)

TABLE 35. Others market size, by region, 2014 - 2018 (USD Million)

TABLE 36. Others market size, by region, 2019 - 2025 (USD Million)

TABLE 37. Biopharmaceutical companies market size, by region, 2014 - 2018 (USD Million)

TABLE 38. Biopharmaceutical companies market size, by region, 2019 - 2025 (USD Million)

TABLE 39. Research institutes market size, by region, 2014 - 2018 (USD Million)

TABLE 40. Research institutes market size, by region, 2019 - 2025 (USD Million)

TABLE 41. Others market size, by region, 2014 - 2018 (USD Million)

TABLE 42. Others market size, by region, 2019 - 2025 (USD Million)

TABLE 43. North America cancer gene therapy market size, by country, 2014 - 2025 (USD Million)

TABLE 44. North America cancer gene therapy market size, by country, 2019 - 2025 (USD Million)

TABLE 45. North America cancer gene therapy market size, by type, 2014 - 2018 (USD Million)

TABLE 46. North America cancer gene therapy market size, by type, 2019 - 2025 (USD Million)

TABLE 47. North America cancer gene therapy market size, by product, 2014 - 2018 (USD Million)

TABLE 48. North America cancer gene therapy market size, by product, 2019 - 2025 (USD Million)

TABLE 49. North America cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)

TABLE 50. North America cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)

TABLE 51. U.S. cancer gene therapy market size, by type, 2014 - 2018 (USD Million)

TABLE 52. U.S. cancer gene therapy market size, by type, 2019 - 2025 (USD Million)

TABLE 53. U.S. cancer gene therapy market size, by product, 2014 - 2018 (USD Million)

TABLE 54. U.S. cancer gene therapy market size, by product, 2019 - 2025 (USD Million)

TABLE 55. U.S. cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)

TABLE 56. U.S. cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)

TABLE 57. Canada cancer gene therapy market size, by type, 2014 - 2018 (USD Million)

TABLE 58. Canada cancer gene therapy market size, by type, 2019 - 2025 (USD Million)

TABLE 59. Canada cancer gene therapy market size, by product, 2014 - 2018 (USD Million)

TABLE 60. Canada cancer gene therapy market size, by product, 2019 - 2025 (USD Million)

TABLE 61. Canada cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)

TABLE 62. Canada cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)

TABLE 63. Europe cancer gene therapy market size, by country, 2014 - 2025 (USD Million)

TABLE 64. Europe cancer gene therapy market size, by country, 2019 - 2025 (USD Million)

TABLE 65. Europe cancer gene therapy market size, by type, 2014 - 2018 (USD Million)

TABLE 66. Europe cancer gene therapy market size, by type, 2019 - 2025 (USD Million)

TABLE 67. Europe cancer gene therapy market size, by product, 2014 - 2018 (USD Million)

TABLE 68. Europe cancer gene therapy market size, by product, 2019 - 2025 (USD Million)

TABLE 69. Europe cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)

TABLE 70. Europe cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)

TABLE 71. Germany cancer gene therapy market size, by type, 2014 - 2018 (USD Million)

TABLE 72. Germany cancer gene therapy market size, by type, 2019 - 2025 (USD Million)

TABLE 73. Germany cancer gene therapy market size, by product, 2014 - 2018 (USD Million)

TABLE 74. Germany cancer gene therapy market size, by product, 2019 - 2025 (USD Million)

TABLE 75. Germany cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)

TABLE 76. Germany cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)

TABLE 77. UK cancer gene therapy market size, by type, 2014 - 2018 (USD Million)

TABLE 78. UK cancer gene therapy market size, by type, 2019 - 2025 (USD Million)

TABLE 79. UK cancer gene therapy market size, by product, 2014 - 2018 (USD Million)

TABLE 80. UK cancer gene therapy market size, by product, 2019 - 2025 (USD Million)

TABLE 81. UK cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)

TABLE 82. UK cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)

TABLE 83. France cancer gene therapy market size, by type, 2014 - 2018 (USD Million)

TABLE 84. France cancer gene therapy market size, by type, 2019 - 2025 (USD Million)

TABLE 85. France cancer gene therapy market size, by product, 2014 - 2018 (USD Million)

TABLE 86. France cancer gene therapy market size, by product, 2019 - 2025 (USD Million)

TABLE 87. France cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)

TABLE 88. France cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)

TABLE 89. Italy cancer gene therapy market size, by type, 2014 - 2018 (USD Million)

TABLE 90. Italy cancer gene therapy market size, by type, 2019 - 2025 (USD Million)

TABLE 91. Italy cancer gene therapy market size, by product, 2014 - 2018 (USD Million)

TABLE 92. Italy cancer gene therapy market size, by product, 2019 - 2025 (USD Million)

TABLE 93. Italy cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)

TABLE 94. Italy cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)

TABLE 95. Spain cancer gene therapy market size, by type, 2014 - 2018 (USD Million)

TABLE 96. Spain cancer gene therapy market size, by type, 2019 - 2025 (USD Million)

TABLE 97. Spain cancer gene therapy market size, by product, 2014 - 2018 (USD Million)

TABLE 98. Spain cancer gene therapy market size, by product, 2019 - 2025 (USD Million)

TABLE 99. Spain cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)

TABLE 100. Spain cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)

TABLE 101. Asia Pacific cancer gene therapy market size, by country, 2014 - 2025 (USD Million)

TABLE 102. Asia Pacific cancer gene therapy market size, by country, 2019 - 2025 (USD Million)

TABLE 103. Asia Pacific cancer gene therapy market size, by type, 2014 - 2018 (USD Million)

TABLE 104. Asia Pacific cancer gene therapy market size, by type, 2019 - 2025 (USD Million)

TABLE 105. Asia Pacific cancer gene therapy market size, by product, 2014 - 2018 (USD Million)

TABLE 106. Asia Pacific cancer gene therapy market size, by product, 2019 - 2025 (USD Million)

TABLE 107. Asia Pacific cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)

TABLE 108. Asia Pacific cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)

TABLE 109. China cancer gene therapy market size, by type, 2014 - 2018 (USD Million)

TABLE 110. China cancer gene therapy market size, by type, 2019 - 2025 (USD Million)

TABLE 111. China cancer gene therapy market size, by product, 2014 - 2018 (USD Million)

TABLE 112. China cancer gene therapy market size, by product, 2019 - 2025 (USD Million)

TABLE 113. China cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)

TABLE 114. China cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)

TABLE 115. Japan cancer gene therapy market size, by type, 2014 - 2018 (USD Million)

TABLE 116. Japan cancer gene therapy market size, by type, 2019 - 2025 (USD Million)

TABLE 117. Japan cancer gene therapy market size, by product, 2014 - 2018 (USD Million)

TABLE 118. Japan cancer gene therapy market size, by product, 2019 - 2025 (USD Million)

TABLE 119. Japan cancer gene therapy market size, by end-use, 2014 - 2018 (USD Million)

TABLE 120. Japan cancer gene therapy market size, by end-use, 2019 - 2025 (USD Million)


Charts & Figures

FIG. 1 Industry segmentation

FIG. 2 Cancer gene therapy market, 2014 - 2018 (USD Million)

FIG. 3 Growth potential analysis, by type

FIG. 4 Growth potential analysis, by product

FIG. 5 Growth potential analysis, by end-use

FIG. 6 Porter’s analysis

FIG. 7 Strategy dashboard

FIG. 8 PESTEL analysis